The submission deadline has passed. The page is kept for reference. View active tenders →
Tender Details
Description / Scope of Work
WAPDA Medical Services invites sealed bids for the execution of a frame work agreement for the supply of medicines to all WAPDA health units across Pakistan. The procurement is planned for financial year 2026-27 with funds already reserved by the procuring agency. This is a significant pharmaceutical supply contract under the Decade of Dams initiative covering medicine procurement across the entire WAPDA healthcare network in Punjab and other provinces. The tender follows the Procurement Notice PRD(L)/WAPDA/343(2025-26) published in The Daily Jang and The Express Tribune on 22 April 2026.
Eligible bidders must be prequalified pharmaceutical manufacturers or sole distributors and importers registered under the Drugs Act 1976 of Pakistan. All bidders must be registered with income tax and sales tax departments and maintained on the active taxpayers list of the Federal Board of Revenue. A bid security of Rs. 500,000 in the form of CDR, payroll order, demand draft, or bank guarantee is mandatory for all submissions. The bidding shall be conducted using the Single Stage-Two Envelope procedure as per Public Procurement Rules 2004.
Bidding documents containing detailed terms, conditions, evaluation criteria, and performance guarantee specifications are available free of cost on www.wapda.gov.pk or from the WAPDA Medical Directorate office at 210 Ferozepur Road, Lahore for Rs. 1,000. Original sealed bids must be submitted at the WAPDA Medical Directorate, WAPDA Hospital Complex, 210 Ferozepur Road, Lahore on or before 24 July 2026 at 11:00 AM. Technical bid opening will occur on the same date at 11:30 AM with bidders' representatives invited to attend. The tender notice is also posted on www.ppra.org.pk.
For Bidders: Our Analysis PAKISTANTENDER INSIGHT
Independent analysis by PakistanTender — not part of the official notice. Always confirm details against the original tender document.
WAPDA is establishing a multi-year framework agreement for medicines across its entire healthcare network—a high-volume, recurring supply contract tied to the Decade of Dams initiative.
Scale is large (national coverage, multiple provinces, pre-allocated budget). This is not a one-off purchase but a structured agreement for FY 2026-27 onwards, suggesting stable volume if renewed. Bidders must be registered manufacturers or authorized distributors; commodity nature means competition will be intense but margins may be predictable given framework pricing structure.
Who can bid: Bidders must be prequalified pharmaceutical manufacturers or sole distributors/importers registered under the Drugs Act 1976. Mandatory registrations: FBR active taxpayer list (income tax and sales tax). No PEC category applies (non-construction). Typically, GST/NTN registration and valid drug licenses are implicit requirements.